Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

Published Jul 17, 2020

Immunotherapy Drug Keytruda Approved For Colon Cancer Patients With Specific Tumor Abnormalities

A new option for the treatment of metastatic colorectal cancer, immune checkpoint inhibitor Keytruda, has been approved by the FDA -- marking historic progress for certain patients

NOW
PLAYING
CAR T-Cell Therapy for Non-Hodgkin Lymphoma
NOW
PLAYING
What Is a Monoclonal Antibody? Already a Cancer Treatment, Trump Got it for COVID-19
NOW
PLAYING
Which Women with Ovarian Cancer Should Get PARP Inhibitors? New Guidelines Offer Recommendations
NOW
PLAYING
5 Truths Sharon Osbourne Learned From Colon Cancer: 'You Realize How Lucky You Are to Be Alive'
NOW
PLAYING
Finally Some Progress For Esophageal Cancer Patients-- Two Immunotherapy Drugs Are Boosting Survival
NOW
PLAYING
FDA Approves Blood Test Which May Let Some Cancer Patients Avoid Additional Biopsies

Treatment: Making Wise Surgery Decisions

SEE MORE   

Treatment: Making Wise Surgery Decisions

There is plenty of marketing information out there about the best surgery techniques, and the best places to have your operation done. Doing your own research is crucial before committing to any treatment.

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.